InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.38
(
-0.15%
)
Bitcoin
55,905.26
(
0.10%
)
Post# of 1509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Smilin_B

Send PM Follow Ignore
Followers 1035
Posts 54534
Boards Moderated 0
Alias Born 03/29/2004

Smilin_B

Re: l2 hunter post# 989

Wednesday, 04/25/2018 9:23:54 AM

Wednesday, April 25, 2018 9:23:54 AM

Post# of 1509
From Greg Gin (IR of EDGE)


We anticipate in the near term reducing the scope of our operations, including the size of Edge’s workforce, in order to preserve the company’s cash resources.

We have currently halted further clinical development of EG-1962 based on the interim analysis outcome. Next steps for the program, if any, are pending completion of our analysis of the full NEWTON 2 data set. We will work with our Board to evaluate all strategic alternatives in order to maximize shareholder value. The company’s next corporate update will likely be the first quarter conference call in early May.

 

Thank you again.




Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up